Thomaides-Brears, Helena B. http://orcid.org/0000-0003-0774-6983
Alkhouri, Naim
Allende, Daniela
Harisinghani, Mukesh
Noureddin, Mazen
Reau, Nancy S.
French, Marika
Pantoja, Carlos
Mouchti, Sofia
Cryer, Donna R. H.
Article History
Received: 24 December 2020
Accepted: 31 May 2021
First Online: 15 June 2021
Declarations
:
: No funding was received for this work. HTB, MF, CP and SF are employees of Perspectum Ltd, a privately funded commercial enterprise that develops medical devices to address unmet clinical needs, including LiverMultiScan®. DRHC is an employee of the Global Liver Institute, a non-profit organization. MN has been on the advisory board for Gilead, Intercept, Pfizer, Fractyl, Novartis, Allergan, Blade, Echosens, EchoSens North America, OWL, Siemens, Roche diagnostic and Abbott; Speaker: Abbott, Echosens, Intercept. MN has received research support from Allergan, BMS, Gilead, Galmed, Galectin, Genfit, Conatus, Enanta, Novartis, Shire and Zydus; MN is a minor shareholder or has stocks in Anaetos and Viking. All other authors have nothing to disclose.